<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d540" origId="Indinavir"><sentence id="DrugDDI.d540.s0" origId="s0" text="Indinavir is an inhibitor of the cytochrome P450 isoform CYP3A4."><entity id="DrugDDI.d540.s0.e0" origId="s0.p0" charOffset="0-9" type="drug" text="Indinavir"/><entity id="DrugDDI.d540.s0.e1" origId="s0.p3" charOffset="33-48" type="drug" text="cytochrome P450"/><pair id="DrugDDI.d540.s0.p0" e1="DrugDDI.d540.s0.e0" e2="DrugDDI.d540.s0.e1" interaction="false"/></sentence><sentence id="DrugDDI.d540.s1" origId="s1" text="Coadministration of CRIXIVAN and drugs primarily metabolized by CYP3A4 may result in increased plasma concentrations of the other drug, which could increase or prolong its therapeutic and adverse effects."><entity id="DrugDDI.d540.s1.e0" origId="s1.p5" charOffset="20-28" type="drug" text="CRIXIVAN"/><entity id="DrugDDI.d540.s1.e1" origId="s1.p7" charOffset="33-38" type="drug" text="drugs"/><entity id="DrugDDI.d540.s1.e2" origId="s1.p9" charOffset="64-70" type="drug" text="CYP3A4"/><entity id="DrugDDI.d540.s1.e3" origId="s1.p13" charOffset="130-134" type="drug" text="drug"/><pair id="DrugDDI.d540.s1.p0" e1="DrugDDI.d540.s1.e0" e2="DrugDDI.d540.s1.e1" interaction="true"/><pair id="DrugDDI.d540.s1.p1" e1="DrugDDI.d540.s1.e0" e2="DrugDDI.d540.s1.e2" interaction="false"/><pair id="DrugDDI.d540.s1.p2" e1="DrugDDI.d540.s1.e0" e2="DrugDDI.d540.s1.e3" interaction="false"/><pair id="DrugDDI.d540.s1.p3" e1="DrugDDI.d540.s1.e1" e2="DrugDDI.d540.s1.e2" interaction="false"/><pair id="DrugDDI.d540.s1.p4" e1="DrugDDI.d540.s1.e1" e2="DrugDDI.d540.s1.e3" interaction="false"/><pair id="DrugDDI.d540.s1.p5" e1="DrugDDI.d540.s1.e2" e2="DrugDDI.d540.s1.e3" interaction="false"/></sentence><sentence id="DrugDDI.d540.s2" origId="s2" text="Indinavir is metabolized by CYP3A4."><entity id="DrugDDI.d540.s2.e0" origId="s2.p22" charOffset="0-9" type="drug" text="Indinavir"/><entity id="DrugDDI.d540.s2.e1" origId="s2.p25" charOffset="28-34" type="drug" text="CYP3A4"/><pair id="DrugDDI.d540.s2.p0" e1="DrugDDI.d540.s2.e0" e2="DrugDDI.d540.s2.e1" interaction="false"/></sentence><sentence id="DrugDDI.d540.s3" origId="s3" text="Drugs that induce CYP3A4 activity would be expected to increase the clearance of indinavir, resulting in lowered plasma concentrations of indinavir."><entity id="DrugDDI.d540.s3.e0" origId="s3.p26" charOffset="0-5" type="drug" text="Drugs"/><entity id="DrugDDI.d540.s3.e1" origId="s3.p29" charOffset="18-24" type="drug" text="CYP3A4"/><entity id="DrugDDI.d540.s3.e2" origId="s3.p36" charOffset="81-90" type="drug" text="indinavir"/><entity id="DrugDDI.d540.s3.e3" origId="s3.p39" charOffset="138-147" type="drug" text="indinavir"/><pair id="DrugDDI.d540.s3.p0" e1="DrugDDI.d540.s3.e0" e2="DrugDDI.d540.s3.e1" interaction="false"/><pair id="DrugDDI.d540.s3.p1" e1="DrugDDI.d540.s3.e0" e2="DrugDDI.d540.s3.e2" interaction="true"/><pair id="DrugDDI.d540.s3.p2" e1="DrugDDI.d540.s3.e0" e2="DrugDDI.d540.s3.e3" interaction="false"/><pair id="DrugDDI.d540.s3.p3" e1="DrugDDI.d540.s3.e1" e2="DrugDDI.d540.s3.e2" interaction="false"/><pair id="DrugDDI.d540.s3.p4" e1="DrugDDI.d540.s3.e1" e2="DrugDDI.d540.s3.e3" interaction="false"/><pair id="DrugDDI.d540.s3.p5" e1="DrugDDI.d540.s3.e2" e2="DrugDDI.d540.s3.e3" interaction="false"/></sentence><sentence id="DrugDDI.d540.s4" origId="s4" text="Coadministration of CRIXIVAN and other drugs that inhibit CYP3A4 may decrease the clearance of indinavir and may result in increased plasma concentrations of indinavir."><entity id="DrugDDI.d540.s4.e0" origId="s4.p41" charOffset="20-28" type="drug" text="CRIXIVAN"/><entity id="DrugDDI.d540.s4.e1" origId="s4.p43" charOffset="39-44" type="drug" text="drugs"/><entity id="DrugDDI.d540.s4.e2" origId="s4.p46" charOffset="58-64" type="drug" text="CYP3A4"/><entity id="DrugDDI.d540.s4.e3" origId="s4.p50" charOffset="95-104" type="drug" text="indinavir"/><entity id="DrugDDI.d540.s4.e4" origId="s4.p55" charOffset="158-167" type="drug" text="indinavir"/><pair id="DrugDDI.d540.s4.p0" e1="DrugDDI.d540.s4.e0" e2="DrugDDI.d540.s4.e1" interaction="true"/><pair id="DrugDDI.d540.s4.p1" e1="DrugDDI.d540.s4.e0" e2="DrugDDI.d540.s4.e2" interaction="false"/><pair id="DrugDDI.d540.s4.p2" e1="DrugDDI.d540.s4.e0" e2="DrugDDI.d540.s4.e3" interaction="false"/><pair id="DrugDDI.d540.s4.p3" e1="DrugDDI.d540.s4.e0" e2="DrugDDI.d540.s4.e4" interaction="false"/><pair id="DrugDDI.d540.s4.p4" e1="DrugDDI.d540.s4.e1" e2="DrugDDI.d540.s4.e2" interaction="false"/><pair id="DrugDDI.d540.s4.p5" e1="DrugDDI.d540.s4.e1" e2="DrugDDI.d540.s4.e3" interaction="false"/><pair id="DrugDDI.d540.s4.p6" e1="DrugDDI.d540.s4.e1" e2="DrugDDI.d540.s4.e4" interaction="false"/><pair id="DrugDDI.d540.s4.p7" e1="DrugDDI.d540.s4.e2" e2="DrugDDI.d540.s4.e3" interaction="false"/><pair id="DrugDDI.d540.s4.p8" e1="DrugDDI.d540.s4.e2" e2="DrugDDI.d540.s4.e4" interaction="false"/><pair id="DrugDDI.d540.s4.p9" e1="DrugDDI.d540.s4.e3" e2="DrugDDI.d540.s4.e4" interaction="false"/></sentence><sentence id="DrugDDI.d540.s5" origId="s5" text="Table 8"/><sentence id="DrugDDI.d540.s6" origId="s6" text="Drugs That Should Not Be Coadministered with CRIXIVAN"><entity id="DrugDDI.d540.s6.e0" origId="s6.p57" charOffset="0-5" type="drug" text="Drugs"/><entity id="DrugDDI.d540.s6.e1" origId="s6.p63" charOffset="45-53" type="drug" text="CRIXIVAN"/><pair id="DrugDDI.d540.s6.p0" e1="DrugDDI.d540.s6.e0" e2="DrugDDI.d540.s6.e1" interaction="true"/></sentence><sentence id="DrugDDI.d540.s7" origId="s7" text="Drug Class: Drug Name Clinical Comment"><entity id="DrugDDI.d540.s7.e0" origId="s7.p64" charOffset="0-4" type="drug" text="Drug"/><entity id="DrugDDI.d540.s7.e1" origId="s7.p66" charOffset="12-16" type="drug" text="Drug"/><pair id="DrugDDI.d540.s7.p0" e1="DrugDDI.d540.s7.e0" e2="DrugDDI.d540.s7.e1" interaction="false"/></sentence><sentence id="DrugDDI.d540.s8" origId="s8" text="Antiarrhythmics: amiodarone"><entity id="DrugDDI.d540.s8.e0" origId="s8.p69" charOffset="0-15" type="drug" text="Antiarrhythmics"/><entity id="DrugDDI.d540.s8.e1" origId="s8.p71" charOffset="17-27" type="drug" text="amiodarone"/><pair id="DrugDDI.d540.s8.p0" e1="DrugDDI.d540.s8.e0" e2="DrugDDI.d540.s8.e1" interaction="false"/></sentence><sentence id="DrugDDI.d540.s9" origId="s9" text="CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias."/><sentence id="DrugDDI.d540.s10" origId="s10" text="Ergot derivatives: dihydroergotamine, ergonovine, ergotamine, methylergonovine"><entity id="DrugDDI.d540.s10.e0" origId="s10.p78" charOffset="0-17" type="drug" text="Ergot derivatives"/><entity id="DrugDDI.d540.s10.e1" origId="s10.p80" charOffset="19-36" type="drug" text="dihydroergotamine"/><entity id="DrugDDI.d540.s10.e2" origId="s10.p81" charOffset="38-48" type="drug" text="ergonovine"/><entity id="DrugDDI.d540.s10.e3" origId="s10.p82" charOffset="50-60" type="drug" text="ergotamine"/><entity id="DrugDDI.d540.s10.e4" origId="s10.p83" charOffset="62-78" type="drug" text="methylergonovine"/><pair id="DrugDDI.d540.s10.p0" e1="DrugDDI.d540.s10.e0" e2="DrugDDI.d540.s10.e1" interaction="false"/><pair id="DrugDDI.d540.s10.p1" e1="DrugDDI.d540.s10.e0" e2="DrugDDI.d540.s10.e2" interaction="false"/><pair id="DrugDDI.d540.s10.p2" e1="DrugDDI.d540.s10.e0" e2="DrugDDI.d540.s10.e3" interaction="false"/><pair id="DrugDDI.d540.s10.p3" e1="DrugDDI.d540.s10.e0" e2="DrugDDI.d540.s10.e4" interaction="false"/><pair id="DrugDDI.d540.s10.p4" e1="DrugDDI.d540.s10.e1" e2="DrugDDI.d540.s10.e2" interaction="false"/><pair id="DrugDDI.d540.s10.p5" e1="DrugDDI.d540.s10.e1" e2="DrugDDI.d540.s10.e3" interaction="false"/><pair id="DrugDDI.d540.s10.p6" e1="DrugDDI.d540.s10.e1" e2="DrugDDI.d540.s10.e4" interaction="false"/><pair id="DrugDDI.d540.s10.p7" e1="DrugDDI.d540.s10.e2" e2="DrugDDI.d540.s10.e3" interaction="false"/><pair id="DrugDDI.d540.s10.p8" e1="DrugDDI.d540.s10.e2" e2="DrugDDI.d540.s10.e4" interaction="false"/><pair id="DrugDDI.d540.s10.p9" e1="DrugDDI.d540.s10.e3" e2="DrugDDI.d540.s10.e4" interaction="false"/></sentence><sentence id="DrugDDI.d540.s11" origId="s11" text="CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues."><entity id="DrugDDI.d540.s11.e0" origId="s11.p89" charOffset="93-98" type="drug" text="ergot"/></sentence><sentence id="DrugDDI.d540.s12" origId="s12" text="Sedative/hypnotics: midazolam, triazolam"><entity id="DrugDDI.d540.s12.e0" origId="s12.p97" charOffset="0-8" type="drug" text="Sedative"/><entity id="DrugDDI.d540.s12.e1" origId="s12.p98" charOffset="9-18" type="drug" text="hypnotics"/><entity id="DrugDDI.d540.s12.e2" origId="s12.p100" charOffset="20-29" type="drug" text="midazolam"/><entity id="DrugDDI.d540.s12.e3" origId="s12.p101" charOffset="31-40" type="drug" text="triazolam"/><pair id="DrugDDI.d540.s12.p0" e1="DrugDDI.d540.s12.e0" e2="DrugDDI.d540.s12.e1" interaction="false"/><pair id="DrugDDI.d540.s12.p1" e1="DrugDDI.d540.s12.e0" e2="DrugDDI.d540.s12.e2" interaction="false"/><pair id="DrugDDI.d540.s12.p2" e1="DrugDDI.d540.s12.e0" e2="DrugDDI.d540.s12.e3" interaction="false"/><pair id="DrugDDI.d540.s12.p3" e1="DrugDDI.d540.s12.e1" e2="DrugDDI.d540.s12.e2" interaction="false"/><pair id="DrugDDI.d540.s12.p4" e1="DrugDDI.d540.s12.e1" e2="DrugDDI.d540.s12.e3" interaction="false"/><pair id="DrugDDI.d540.s12.p5" e1="DrugDDI.d540.s12.e2" e2="DrugDDI.d540.s12.e3" interaction="false"/></sentence><sentence id="DrugDDI.d540.s13" origId="s13" text="CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression."/><sentence id="DrugDDI.d540.s14" origId="s14" text="GI motility agents: cisapride"><entity id="DrugDDI.d540.s14.e0" origId="s14.p114" charOffset="20-29" type="drug" text="cisapride"/></sentence><sentence id="DrugDDI.d540.s15" origId="s15" text="CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias."/><sentence id="DrugDDI.d540.s16" origId="s16" text="Neuroleptic: pimozide"><entity id="DrugDDI.d540.s16.e0" origId="s16.p121" charOffset="0-11" type="drug" text="Neuroleptic"/><entity id="DrugDDI.d540.s16.e1" origId="s16.p123" charOffset="13-21" type="drug" text="pimozide"/><pair id="DrugDDI.d540.s16.p0" e1="DrugDDI.d540.s16.e0" e2="DrugDDI.d540.s16.e1" interaction="false"/></sentence><sentence id="DrugDDI.d540.s17" origId="s17" text="CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias."/><sentence id="DrugDDI.d540.s18" origId="s18" text="Herbal products: St. John?s wort (Hypericum perforatum)"><entity id="DrugDDI.d540.s18.e0" origId="s18.p134" charOffset="34-54" type="drug" text="Hypericum perforatum"/></sentence><sentence id="DrugDDI.d540.s19" origId="s19" text="May lead to loss of virologic response and possible resistance to CRIXIVAN or to the class of protease inhibitors."><entity id="DrugDDI.d540.s19.e0" origId="s19.p142" charOffset="66-74" type="drug" text="CRIXIVAN"/><entity id="DrugDDI.d540.s19.e1" origId="s19.p145" charOffset="94-113" type="drug" text="protease inhibitors"/><pair id="DrugDDI.d540.s19.p0" e1="DrugDDI.d540.s19.e0" e2="DrugDDI.d540.s19.e1" interaction="false"/></sentence><sentence id="DrugDDI.d540.s20" origId="s20" text="Antimycobacterial: rifampin"><entity id="DrugDDI.d540.s20.e0" origId="s20.p148" charOffset="19-27" type="drug" text="rifampin"/></sentence><sentence id="DrugDDI.d540.s21" origId="s21" text="May lead to loss of virologic response and possible resistance to CRIXIVAN or to the class of protease inhibitors or other coadministered antiretroviral agents."><entity id="DrugDDI.d540.s21.e0" origId="s21.p155" charOffset="66-74" type="drug" text="CRIXIVAN"/><entity id="DrugDDI.d540.s21.e1" origId="s21.p158" charOffset="94-113" type="drug" text="protease inhibitors"/><entity id="DrugDDI.d540.s21.e2" origId="s21.p160" charOffset="138-159" type="drug" text="antiretroviral agents"/><pair id="DrugDDI.d540.s21.p0" e1="DrugDDI.d540.s21.e0" e2="DrugDDI.d540.s21.e1" interaction="false"/><pair id="DrugDDI.d540.s21.p1" e1="DrugDDI.d540.s21.e0" e2="DrugDDI.d540.s21.e2" interaction="false"/><pair id="DrugDDI.d540.s21.p2" e1="DrugDDI.d540.s21.e1" e2="DrugDDI.d540.s21.e2" interaction="false"/></sentence><sentence id="DrugDDI.d540.s22" origId="s22" text="HMG-CoA Reductase inhibitors: lovastatin, simvastatin"><entity id="DrugDDI.d540.s22.e0" origId="s22.p161" charOffset="0-28" type="drug" text="HMG-CoA Reductase inhibitors"/><entity id="DrugDDI.d540.s22.e1" origId="s22.p163" charOffset="30-40" type="drug" text="lovastatin"/><entity id="DrugDDI.d540.s22.e2" origId="s22.p164" charOffset="42-53" type="drug" text="simvastatin"/><pair id="DrugDDI.d540.s22.p0" e1="DrugDDI.d540.s22.e0" e2="DrugDDI.d540.s22.e1" interaction="false"/><pair id="DrugDDI.d540.s22.p1" e1="DrugDDI.d540.s22.e0" e2="DrugDDI.d540.s22.e2" interaction="false"/><pair id="DrugDDI.d540.s22.p2" e1="DrugDDI.d540.s22.e1" e2="DrugDDI.d540.s22.e2" interaction="false"/></sentence><sentence id="DrugDDI.d540.s23" origId="s23" text="Potential for serious reactions such as risk of myopathy including rhabdomyolysis."/><sentence id="DrugDDI.d540.s24" origId="s24" text="Protease inhibitor: atazanavir"><entity id="DrugDDI.d540.s24.e0" origId="s24.p171" charOffset="0-18" type="drug" text="Protease inhibitor"/><entity id="DrugDDI.d540.s24.e1" origId="s24.p173" charOffset="20-30" type="drug" text="atazanavir"/><pair id="DrugDDI.d540.s24.p0" e1="DrugDDI.d540.s24.e0" e2="DrugDDI.d540.s24.e1" interaction="false"/></sentence><sentence id="DrugDDI.d540.s25" origId="s25" text="Both CRIXIVAN and atazanavir are associated with indirect (unconjugated) hyperbilirubinemia."><entity id="DrugDDI.d540.s25.e0" origId="s25.p175" charOffset="5-13" type="drug" text="CRIXIVAN"/><entity id="DrugDDI.d540.s25.e1" origId="s25.p177" charOffset="18-28" type="drug" text="atazanavir"/><pair id="DrugDDI.d540.s25.p0" e1="DrugDDI.d540.s25.e0" e2="DrugDDI.d540.s25.e1" interaction="false"/></sentence><sentence id="DrugDDI.d540.s26" origId="s26" text="Combinations of these drugs have not been studied and coadministration of CRIXIVAN and atazanavir is not recommended."><entity id="DrugDDI.d540.s26.e0" origId="s26.p186" charOffset="22-27" type="drug" text="drugs"/><entity id="DrugDDI.d540.s26.e1" origId="s26.p193" charOffset="74-82" type="drug" text="CRIXIVAN"/><entity id="DrugDDI.d540.s26.e2" origId="s26.p195" charOffset="87-97" type="drug" text="atazanavir"/><pair id="DrugDDI.d540.s26.p0" e1="DrugDDI.d540.s26.e0" e2="DrugDDI.d540.s26.e1" interaction="false"/><pair id="DrugDDI.d540.s26.p1" e1="DrugDDI.d540.s26.e0" e2="DrugDDI.d540.s26.e2" interaction="false"/><pair id="DrugDDI.d540.s26.p2" e1="DrugDDI.d540.s26.e1" e2="DrugDDI.d540.s26.e2" interaction="true"/></sentence><sentence id="DrugDDI.d540.s27" origId="s27" text="Table 9"/><sentence id="DrugDDI.d540.s28" origId="s28" text="Established and Other Potentially Significant Drug Interactions: Alteration in Dose or Regimen May Be Recommended Based on Drug Interaction Studies or Predicted Interaction"/><sentence id="DrugDDI.d540.s29" origId="s29" text="Drug Name"><entity id="DrugDDI.d540.s29.e0" origId="s29.p214" charOffset="0-4" type="drug" text="Drug"/></sentence><sentence id="DrugDDI.d540.s30" origId="s30" text="Effect"/><sentence id="DrugDDI.d540.s31" origId="s31" text="Clinical Comment"/><sentence id="DrugDDI.d540.s32" origId="s32" text="HIV Antiviral Agents"><entity id="DrugDDI.d540.s32.e0" origId="s32.p217" charOffset="4-20" type="drug" text="Antiviral Agents"/></sentence><sentence id="DrugDDI.d540.s33" origId="s33" text="Delavirdine"><entity id="DrugDDI.d540.s33.e0" origId="s33.p218" charOffset="0-11" type="drug" text="Delavirdine"/></sentence><sentence id="DrugDDI.d540.s34" origId="s34" text="? indinavir concentration"><entity id="DrugDDI.d540.s34.e0" origId="s34.p220" charOffset="2-11" type="drug" text="indinavir"/></sentence><sentence id="DrugDDI.d540.s35" origId="s35" text="Dose reduction of CRIXIVAN to 600 mg every 8 hours should be considered when taking delavirdine 400 mg three times a day."><entity id="DrugDDI.d540.s35.e0" origId="s35.p222" charOffset="18-26" type="drug" text="CRIXIVAN"/><entity id="DrugDDI.d540.s35.e1" origId="s35.p228" charOffset="84-95" type="drug" text="delavirdine"/><pair id="DrugDDI.d540.s35.p0" e1="DrugDDI.d540.s35.e0" e2="DrugDDI.d540.s35.e1" interaction="true"/></sentence><sentence id="DrugDDI.d540.s36" origId="s36" text="Didanosine"><entity id="DrugDDI.d540.s36.e0" origId="s36.p230" charOffset="0-10" type="drug" text="Didanosine"/></sentence><sentence id="DrugDDI.d540.s37" origId="s37" text="Indinavir and didanosine formulations containing buffer should be administered at least one hour apart on an empty stomach."><entity id="DrugDDI.d540.s37.e0" origId="s37.p231" charOffset="0-9" type="drug" text="Indinavir"/><entity id="DrugDDI.d540.s37.e1" origId="s37.p233" charOffset="14-24" type="drug" text="didanosine"/><entity id="DrugDDI.d540.s37.e2" origId="s37.p235" charOffset="49-55" type="drug" text="buffer"/><pair id="DrugDDI.d540.s37.p0" e1="DrugDDI.d540.s37.e0" e2="DrugDDI.d540.s37.e1" interaction="true"/><pair id="DrugDDI.d540.s37.p1" e1="DrugDDI.d540.s37.e0" e2="DrugDDI.d540.s37.e2" interaction="false"/><pair id="DrugDDI.d540.s37.p2" e1="DrugDDI.d540.s37.e1" e2="DrugDDI.d540.s37.e2" interaction="false"/></sentence><sentence id="DrugDDI.d540.s38" origId="s38" text="Efavirenz"><entity id="DrugDDI.d540.s38.e0" origId="s38.p241" charOffset="0-9" type="drug" text="Efavirenz"/></sentence><sentence id="DrugDDI.d540.s39" origId="s39" text="?indinavir concentration"/><sentence id="DrugDDI.d540.s40" origId="s40" text="The optimal dose of indinavir, when given in combination with efavirenz, is not known."><entity id="DrugDDI.d540.s40.e0" origId="s40.p244" charOffset="20-29" type="drug" text="indinavir"/><entity id="DrugDDI.d540.s40.e1" origId="s40.p248" charOffset="62-71" type="drug" text="efavirenz"/><pair id="DrugDDI.d540.s40.p0" e1="DrugDDI.d540.s40.e0" e2="DrugDDI.d540.s40.e1" interaction="false"/></sentence><sentence id="DrugDDI.d540.s41" origId="s41" text="Increasing the indinavir dose to 1000 mg every 8 hours does not compensate for the increased indinavir metabolism due to efavirenz."><entity id="DrugDDI.d540.s41.e0" origId="s41.p253" charOffset="15-24" type="drug" text="indinavir"/><entity id="DrugDDI.d540.s41.e1" origId="s41.p258" charOffset="93-102" type="drug" text="indinavir"/><entity id="DrugDDI.d540.s41.e2" origId="s41.p259" charOffset="121-130" type="drug" text="efavirenz"/><pair id="DrugDDI.d540.s41.p0" e1="DrugDDI.d540.s41.e0" e2="DrugDDI.d540.s41.e1" interaction="false"/><pair id="DrugDDI.d540.s41.p1" e1="DrugDDI.d540.s41.e0" e2="DrugDDI.d540.s41.e2" interaction="false"/><pair id="DrugDDI.d540.s41.p2" e1="DrugDDI.d540.s41.e1" e2="DrugDDI.d540.s41.e2" interaction="false"/></sentence><sentence id="DrugDDI.d540.s42" origId="s42" text="Nelfinavir"><entity id="DrugDDI.d540.s42.e0" origId="s42.p260" charOffset="0-10" type="drug" text="Nelfinavir"/></sentence><sentence id="DrugDDI.d540.s43" origId="s43" text="? indinavir concentration"><entity id="DrugDDI.d540.s43.e0" origId="s43.p262" charOffset="2-11" type="drug" text="indinavir"/></sentence><sentence id="DrugDDI.d540.s44" origId="s44" text="The appropriate doses for this combination, with respect to efficacy and safety, have not been established."/><sentence id="DrugDDI.d540.s45" origId="s45" text="Nevirapine"><entity id="DrugDDI.d540.s45.e0" origId="s45.p273" charOffset="0-10" type="drug" text="Nevirapine"/></sentence><sentence id="DrugDDI.d540.s46" origId="s46" text="? indinavir concentration"><entity id="DrugDDI.d540.s46.e0" origId="s46.p274" charOffset="2-11" type="drug" text="indinavir"/></sentence><sentence id="DrugDDI.d540.s47" origId="s47" text="Indinavir concentrations may be decreased in the presence of nevirapine."><entity id="DrugDDI.d540.s47.e0" origId="s47.p275" charOffset="0-9" type="drug" text="Indinavir"/><entity id="DrugDDI.d540.s47.e1" origId="s47.p280" charOffset="61-71" type="drug" text="nevirapine"/><pair id="DrugDDI.d540.s47.p0" e1="DrugDDI.d540.s47.e0" e2="DrugDDI.d540.s47.e1" interaction="true"/></sentence><sentence id="DrugDDI.d540.s48" origId="s48" text="The appropriate doses for this combination, with respect to efficacy and safety, have not been established."/><sentence id="DrugDDI.d540.s49" origId="s49" text="Ritonavir"><entity id="DrugDDI.d540.s49.e0" origId="s49.p291" charOffset="0-9" type="drug" text="Ritonavir"/></sentence><sentence id="DrugDDI.d540.s50" origId="s50" text="? indinavir concentration ? ritonavir concentration"><entity id="DrugDDI.d540.s50.e0" origId="s50.p293" charOffset="2-11" type="drug" text="indinavir"/><entity id="DrugDDI.d540.s50.e1" origId="s50.p294" charOffset="28-37" type="drug" text="ritonavir"/><pair id="DrugDDI.d540.s50.p0" e1="DrugDDI.d540.s50.e0" e2="DrugDDI.d540.s50.e1" interaction="false"/></sentence><sentence id="DrugDDI.d540.s51" origId="s51" text="The appropriate doses for this combination, with respect to efficacy and safety, have not been established."/><sentence id="DrugDDI.d540.s52" origId="s52" text="Preliminary clinical data suggest that the incidence of nephrolithiasis is higher in patients receiving indinavir in combination with ritonavir than those receiving CRIXIVAN 800 mg q8h."><entity id="DrugDDI.d540.s52.e0" origId="s52.p313" charOffset="104-113" type="drug" text="indinavir"/><entity id="DrugDDI.d540.s52.e1" origId="s52.p315" charOffset="134-143" type="drug" text="ritonavir"/><entity id="DrugDDI.d540.s52.e2" origId="s52.p316" charOffset="165-173" type="drug" text="CRIXIVAN"/><pair id="DrugDDI.d540.s52.p0" e1="DrugDDI.d540.s52.e0" e2="DrugDDI.d540.s52.e1" interaction="true"/><pair id="DrugDDI.d540.s52.p1" e1="DrugDDI.d540.s52.e0" e2="DrugDDI.d540.s52.e2" interaction="false"/><pair id="DrugDDI.d540.s52.p2" e1="DrugDDI.d540.s52.e1" e2="DrugDDI.d540.s52.e2" interaction="false"/></sentence><sentence id="DrugDDI.d540.s53" origId="s53" text="Saquinavir"><entity id="DrugDDI.d540.s53.e0" origId="s53.p317" charOffset="0-10" type="drug" text="Saquinavir"/></sentence><sentence id="DrugDDI.d540.s54" origId="s54" text="? saquinavir concentration"><entity id="DrugDDI.d540.s54.e0" origId="s54.p319" charOffset="2-12" type="drug" text="saquinavir"/></sentence><sentence id="DrugDDI.d540.s55" origId="s55" text="The appropriate doses for this combination, with respect to efficacy and safety, have not been established."/><sentence id="DrugDDI.d540.s56" origId="s56" text="Other Agents"/><sentence id="DrugDDI.d540.s57" origId="s57" text="Antiarrhythmics: bepridil, lidocaine (systemic) and quinidine"><entity id="DrugDDI.d540.s57.e0" origId="s57.p331" charOffset="0-15" type="drug" text="Antiarrhythmics"/><entity id="DrugDDI.d540.s57.e1" origId="s57.p333" charOffset="17-25" type="drug" text="bepridil"/><entity id="DrugDDI.d540.s57.e2" origId="s57.p334" charOffset="27-36" type="drug" text="lidocaine"/><entity id="DrugDDI.d540.s57.e3" origId="s57.p339" charOffset="52-61" type="drug" text="quinidine"/><pair id="DrugDDI.d540.s57.p0" e1="DrugDDI.d540.s57.e0" e2="DrugDDI.d540.s57.e1" interaction="false"/><pair id="DrugDDI.d540.s57.p1" e1="DrugDDI.d540.s57.e0" e2="DrugDDI.d540.s57.e2" interaction="false"/><pair id="DrugDDI.d540.s57.p2" e1="DrugDDI.d540.s57.e0" e2="DrugDDI.d540.s57.e3" interaction="false"/><pair id="DrugDDI.d540.s57.p3" e1="DrugDDI.d540.s57.e1" e2="DrugDDI.d540.s57.e2" interaction="false"/><pair id="DrugDDI.d540.s57.p4" e1="DrugDDI.d540.s57.e1" e2="DrugDDI.d540.s57.e3" interaction="false"/><pair id="DrugDDI.d540.s57.p5" e1="DrugDDI.d540.s57.e2" e2="DrugDDI.d540.s57.e3" interaction="false"/></sentence><sentence id="DrugDDI.d540.s58" origId="s58" text="? antiarrhythmic agents concentration"><entity id="DrugDDI.d540.s58.e0" origId="s58.p341" charOffset="2-22" type="drug" text="antiarrhythmic agent"/></sentence><sentence id="DrugDDI.d540.s59" origId="s59" text="Caution is warranted and therapeutic concentration monitoring is recommended for antiarrhythmics when coadministered with CRIXIVAN."><entity id="DrugDDI.d540.s59.e0" origId="s59.p349" charOffset="81-96" type="drug" text="antiarrhythmics"/><entity id="DrugDDI.d540.s59.e1" origId="s59.p352" charOffset="122-130" type="drug" text="CRIXIVAN"/><pair id="DrugDDI.d540.s59.p0" e1="DrugDDI.d540.s59.e0" e2="DrugDDI.d540.s59.e1" interaction="true"/></sentence><sentence id="DrugDDI.d540.s60" origId="s60" text="Anticonvulsants: carbamazepine, phenobarbital, phenytoin"><entity id="DrugDDI.d540.s60.e0" origId="s60.p353" charOffset="0-15" type="drug" text="Anticonvulsants"/><entity id="DrugDDI.d540.s60.e1" origId="s60.p355" charOffset="17-30" type="drug" text="carbamazepine"/><entity id="DrugDDI.d540.s60.e2" origId="s60.p356" charOffset="32-45" type="drug" text="phenobarbital"/><entity id="DrugDDI.d540.s60.e3" origId="s60.p357" charOffset="47-56" type="drug" text="phenytoin"/><pair id="DrugDDI.d540.s60.p0" e1="DrugDDI.d540.s60.e0" e2="DrugDDI.d540.s60.e1" interaction="false"/><pair id="DrugDDI.d540.s60.p1" e1="DrugDDI.d540.s60.e0" e2="DrugDDI.d540.s60.e2" interaction="false"/><pair id="DrugDDI.d540.s60.p2" e1="DrugDDI.d540.s60.e0" e2="DrugDDI.d540.s60.e3" interaction="false"/><pair id="DrugDDI.d540.s60.p3" e1="DrugDDI.d540.s60.e1" e2="DrugDDI.d540.s60.e2" interaction="false"/><pair id="DrugDDI.d540.s60.p4" e1="DrugDDI.d540.s60.e1" e2="DrugDDI.d540.s60.e3" interaction="false"/><pair id="DrugDDI.d540.s60.p5" e1="DrugDDI.d540.s60.e2" e2="DrugDDI.d540.s60.e3" interaction="false"/></sentence><sentence id="DrugDDI.d540.s61" origId="s61" text="? indinavir concentration"><entity id="DrugDDI.d540.s61.e0" origId="s61.p358" charOffset="2-11" type="drug" text="indinavir"/></sentence><sentence id="DrugDDI.d540.s62" origId="s62" text="Use with caution."/><sentence id="DrugDDI.d540.s63" origId="s63" text="CRIXIVAN may not be effective due to decreased indinavir concentrations in patients taking these agents concomitantly."><entity id="DrugDDI.d540.s63.e0" origId="s63.p361" charOffset="0-8" type="drug" text="CRIXIVAN"/><entity id="DrugDDI.d540.s63.e1" origId="s63.p366" charOffset="47-56" type="drug" text="indinavir"/><pair id="DrugDDI.d540.s63.p0" e1="DrugDDI.d540.s63.e0" e2="DrugDDI.d540.s63.e1" interaction="false"/></sentence><sentence id="DrugDDI.d540.s64" origId="s64" text="Calcium Channel Blockers, Dihydropyridine: e.g., felodipine, nifedipine, nicardipine"><entity id="DrugDDI.d540.s64.e0" origId="s64.p370" charOffset="0-24" type="drug" text="Calcium Channel Blockers"/><entity id="DrugDDI.d540.s64.e1" origId="s64.p371" charOffset="26-41" type="drug" text="Dihydropyridine"/><entity id="DrugDDI.d540.s64.e2" origId="s64.p375" charOffset="49-59" type="drug" text="felodipine"/><entity id="DrugDDI.d540.s64.e3" origId="s64.p376" charOffset="61-71" type="drug" text="nifedipine"/><entity id="DrugDDI.d540.s64.e4" origId="s64.p377" charOffset="73-84" type="drug" text="nicardipine"/><pair id="DrugDDI.d540.s64.p0" e1="DrugDDI.d540.s64.e0" e2="DrugDDI.d540.s64.e1" interaction="false"/><pair id="DrugDDI.d540.s64.p1" e1="DrugDDI.d540.s64.e0" e2="DrugDDI.d540.s64.e2" interaction="false"/><pair id="DrugDDI.d540.s64.p2" e1="DrugDDI.d540.s64.e0" e2="DrugDDI.d540.s64.e3" interaction="false"/><pair id="DrugDDI.d540.s64.p3" e1="DrugDDI.d540.s64.e0" e2="DrugDDI.d540.s64.e4" interaction="false"/><pair id="DrugDDI.d540.s64.p4" e1="DrugDDI.d540.s64.e1" e2="DrugDDI.d540.s64.e2" interaction="false"/><pair id="DrugDDI.d540.s64.p5" e1="DrugDDI.d540.s64.e1" e2="DrugDDI.d540.s64.e3" interaction="false"/><pair id="DrugDDI.d540.s64.p6" e1="DrugDDI.d540.s64.e1" e2="DrugDDI.d540.s64.e4" interaction="false"/><pair id="DrugDDI.d540.s64.p7" e1="DrugDDI.d540.s64.e2" e2="DrugDDI.d540.s64.e3" interaction="false"/><pair id="DrugDDI.d540.s64.p8" e1="DrugDDI.d540.s64.e2" e2="DrugDDI.d540.s64.e4" interaction="false"/><pair id="DrugDDI.d540.s64.p9" e1="DrugDDI.d540.s64.e3" e2="DrugDDI.d540.s64.e4" interaction="false"/></sentence><sentence id="DrugDDI.d540.s65" origId="s65" text="? dihydropyridine calcium channel blockers concentration"><entity id="DrugDDI.d540.s65.e0" origId="s65.p379" charOffset="18-42" type="drug" text="calcium channel blockers"/></sentence><sentence id="DrugDDI.d540.s66" origId="s66" text="Caution is warranted and clinical monitoring of patients is recommended."/><sentence id="DrugDDI.d540.s67" origId="s67" text="Clarithromycin"><entity id="DrugDDI.d540.s67.e0" origId="s67.p388" charOffset="0-14" type="drug" text="Clarithromycin"/></sentence><sentence id="DrugDDI.d540.s68" origId="s68" text="? clarithromycin concentration ? indinavir concentration"><entity id="DrugDDI.d540.s68.e0" origId="s68.p390" charOffset="2-16" type="drug" text="clarithromycin"/><entity id="DrugDDI.d540.s68.e1" origId="s68.p391" charOffset="33-42" type="drug" text="indinavir"/><pair id="DrugDDI.d540.s68.p0" e1="DrugDDI.d540.s68.e0" e2="DrugDDI.d540.s68.e1" interaction="false"/></sentence><sentence id="DrugDDI.d540.s69" origId="s69" text="The appropriate doses for this combination, with respect to efficacy and safety, have not been established."/><sentence id="DrugDDI.d540.s70" origId="s70" text="HMG-CoA Reductase Inhibitor: atorvastatin"><entity id="DrugDDI.d540.s70.e0" origId="s70.p402" charOffset="0-27" type="drug" text="hmg-coa reductase inhibitor"/><entity id="DrugDDI.d540.s70.e1" origId="s70.p404" charOffset="29-41" type="drug" text="atorvastatin"/><pair id="DrugDDI.d540.s70.p0" e1="DrugDDI.d540.s70.e0" e2="DrugDDI.d540.s70.e1" interaction="false"/></sentence><sentence id="DrugDDI.d540.s71" origId="s71" text="? atorvastatin concentration"><entity id="DrugDDI.d540.s71.e0" origId="s71.p406" charOffset="2-14" type="drug" text="atorvastatin"/></sentence><sentence id="DrugDDI.d540.s72" origId="s72" text="Use lowest possible dose of atorvastatin with careful monitoring, or consider HMG-CoA reductase inhibitors that are not primarily metabolized by CYP3A4, such as pravastatin, fluvastatin, or rosuvastatin in combination with CRIXIVAN."><entity id="DrugDDI.d540.s72.e0" origId="s72.p409" charOffset="28-40" type="drug" text="atorvastatin"/><entity id="DrugDDI.d540.s72.e1" origId="s72.p413" charOffset="78-106" type="drug" text="HMG-CoA reductase inhibitors"/><entity id="DrugDDI.d540.s72.e2" origId="s72.p418" charOffset="145-151" type="drug" text="CYP3A4"/><entity id="DrugDDI.d540.s72.e3" origId="s72.p419" charOffset="161-172" type="drug" text="pravastatin"/><entity id="DrugDDI.d540.s72.e4" origId="s72.p420" charOffset="174-185" type="drug" text="fluvastatin"/><entity id="DrugDDI.d540.s72.e5" origId="s72.p422" charOffset="190-202" type="drug" text="rosuvastatin"/><entity id="DrugDDI.d540.s72.e6" origId="s72.p424" charOffset="223-231" type="drug" text="CRIXIVAN"/><pair id="DrugDDI.d540.s72.p0" e1="DrugDDI.d540.s72.e0" e2="DrugDDI.d540.s72.e1" interaction="false"/><pair id="DrugDDI.d540.s72.p1" e1="DrugDDI.d540.s72.e0" e2="DrugDDI.d540.s72.e2" interaction="false"/><pair id="DrugDDI.d540.s72.p2" e1="DrugDDI.d540.s72.e0" e2="DrugDDI.d540.s72.e3" interaction="false"/><pair id="DrugDDI.d540.s72.p3" e1="DrugDDI.d540.s72.e0" e2="DrugDDI.d540.s72.e4" interaction="false"/><pair id="DrugDDI.d540.s72.p4" e1="DrugDDI.d540.s72.e0" e2="DrugDDI.d540.s72.e5" interaction="false"/><pair id="DrugDDI.d540.s72.p5" e1="DrugDDI.d540.s72.e0" e2="DrugDDI.d540.s72.e6" interaction="false"/><pair id="DrugDDI.d540.s72.p6" e1="DrugDDI.d540.s72.e1" e2="DrugDDI.d540.s72.e2" interaction="false"/><pair id="DrugDDI.d540.s72.p7" e1="DrugDDI.d540.s72.e1" e2="DrugDDI.d540.s72.e3" interaction="false"/><pair id="DrugDDI.d540.s72.p8" e1="DrugDDI.d540.s72.e1" e2="DrugDDI.d540.s72.e4" interaction="false"/><pair id="DrugDDI.d540.s72.p9" e1="DrugDDI.d540.s72.e1" e2="DrugDDI.d540.s72.e5" interaction="false"/><pair id="DrugDDI.d540.s72.p10" e1="DrugDDI.d540.s72.e1" e2="DrugDDI.d540.s72.e6" interaction="false"/><pair id="DrugDDI.d540.s72.p11" e1="DrugDDI.d540.s72.e2" e2="DrugDDI.d540.s72.e3" interaction="false"/><pair id="DrugDDI.d540.s72.p12" e1="DrugDDI.d540.s72.e2" e2="DrugDDI.d540.s72.e4" interaction="false"/><pair id="DrugDDI.d540.s72.p13" e1="DrugDDI.d540.s72.e2" e2="DrugDDI.d540.s72.e5" interaction="false"/><pair id="DrugDDI.d540.s72.p14" e1="DrugDDI.d540.s72.e2" e2="DrugDDI.d540.s72.e6" interaction="false"/><pair id="DrugDDI.d540.s72.p15" e1="DrugDDI.d540.s72.e3" e2="DrugDDI.d540.s72.e4" interaction="false"/><pair id="DrugDDI.d540.s72.p16" e1="DrugDDI.d540.s72.e3" e2="DrugDDI.d540.s72.e5" interaction="false"/><pair id="DrugDDI.d540.s72.p17" e1="DrugDDI.d540.s72.e3" e2="DrugDDI.d540.s72.e6" interaction="false"/><pair id="DrugDDI.d540.s72.p18" e1="DrugDDI.d540.s72.e4" e2="DrugDDI.d540.s72.e5" interaction="false"/><pair id="DrugDDI.d540.s72.p19" e1="DrugDDI.d540.s72.e4" e2="DrugDDI.d540.s72.e6" interaction="false"/><pair id="DrugDDI.d540.s72.p20" e1="DrugDDI.d540.s72.e5" e2="DrugDDI.d540.s72.e6" interaction="false"/></sentence><sentence id="DrugDDI.d540.s73" origId="s73" text="Immunosuppressants: cyclosporine, tacrolimus, sirolimus"><entity id="DrugDDI.d540.s73.e0" origId="s73.p425" charOffset="0-18" type="drug" text="Immunosuppressants"/><entity id="DrugDDI.d540.s73.e1" origId="s73.p427" charOffset="20-32" type="drug" text="cyclosporine"/><entity id="DrugDDI.d540.s73.e2" origId="s73.p428" charOffset="34-44" type="drug" text="tacrolimus"/><entity id="DrugDDI.d540.s73.e3" origId="s73.p429" charOffset="46-55" type="drug" text="sirolimus"/><pair id="DrugDDI.d540.s73.p0" e1="DrugDDI.d540.s73.e0" e2="DrugDDI.d540.s73.e1" interaction="false"/><pair id="DrugDDI.d540.s73.p1" e1="DrugDDI.d540.s73.e0" e2="DrugDDI.d540.s73.e2" interaction="false"/><pair id="DrugDDI.d540.s73.p2" e1="DrugDDI.d540.s73.e0" e2="DrugDDI.d540.s73.e3" interaction="false"/><pair id="DrugDDI.d540.s73.p3" e1="DrugDDI.d540.s73.e1" e2="DrugDDI.d540.s73.e2" interaction="false"/><pair id="DrugDDI.d540.s73.p4" e1="DrugDDI.d540.s73.e1" e2="DrugDDI.d540.s73.e3" interaction="false"/><pair id="DrugDDI.d540.s73.p5" e1="DrugDDI.d540.s73.e2" e2="DrugDDI.d540.s73.e3" interaction="false"/></sentence><sentence id="DrugDDI.d540.s74" origId="s74" text="? immunosuppressant agents concentration"><entity id="DrugDDI.d540.s74.e0" origId="s74.p431" charOffset="2-26" type="drug" text="immunosuppressant agents"/></sentence><sentence id="DrugDDI.d540.s75" origId="s75" text="Plasma concentrations may be increased by CRIXIVAN."><entity id="DrugDDI.d540.s75.e0" origId="s75.p436" charOffset="42-50" type="drug" text="CRIXIVAN"/></sentence><sentence id="DrugDDI.d540.s76" origId="s76" text="Itraconazole"><entity id="DrugDDI.d540.s76.e0" origId="s76.p437" charOffset="0-12" type="drug" text="Itraconazole"/></sentence><sentence id="DrugDDI.d540.s77" origId="s77" text="? indinavir concentration"><entity id="DrugDDI.d540.s77.e0" origId="s77.p439" charOffset="2-11" type="drug" text="indinavir"/></sentence><sentence id="DrugDDI.d540.s78" origId="s78" text="Dose reduction of CRIXIVAN to 600 mg every 8 hours is recommended when administering itraconazole concurrently."><entity id="DrugDDI.d540.s78.e0" origId="s78.p441" charOffset="18-26" type="drug" text="CRIXIVAN"/><entity id="DrugDDI.d540.s78.e1" origId="s78.p446" charOffset="85-97" type="drug" text="itraconazole"/><pair id="DrugDDI.d540.s78.p0" e1="DrugDDI.d540.s78.e0" e2="DrugDDI.d540.s78.e1" interaction="true"/></sentence><sentence id="DrugDDI.d540.s79" origId="s79" text="Ketoconazole"><entity id="DrugDDI.d540.s79.e0" origId="s79.p447" charOffset="0-12" type="drug" text="Ketoconazole"/></sentence><sentence id="DrugDDI.d540.s80" origId="s80" text="? indinavir concentration"><entity id="DrugDDI.d540.s80.e0" origId="s80.p449" charOffset="2-11" type="drug" text="indinavir"/></sentence><sentence id="DrugDDI.d540.s81" origId="s81" text="Dose reduction of CRIXIVAN to 600 mg every 8 hours should be considered."><entity id="DrugDDI.d540.s81.e0" origId="s81.p451" charOffset="18-26" type="drug" text="CRIXIVAN"/></sentence><sentence id="DrugDDI.d540.s82" origId="s82" text="Rifabutin"><entity id="DrugDDI.d540.s82.e0" origId="s82.p456" charOffset="0-9" type="drug" text="Rifabutin"/></sentence><sentence id="DrugDDI.d540.s83" origId="s83" text="? indinavir concentration ? rifabutin concentration"><entity id="DrugDDI.d540.s83.e0" origId="s83.p457" charOffset="2-11" type="drug" text="indinavir"/><entity id="DrugDDI.d540.s83.e1" origId="s83.p458" charOffset="28-37" type="drug" text="rifabutin"/><pair id="DrugDDI.d540.s83.p0" e1="DrugDDI.d540.s83.e0" e2="DrugDDI.d540.s83.e1" interaction="false"/></sentence><sentence id="DrugDDI.d540.s84" origId="s84" text="Dose reduction of rifabutin to half the standard dose and a dose increase of CRIXIVAN to 1000 mg (three 333-mg capsules) every 8 hours are recommended when rifabutin and CRIXIVAN are coadministered."><entity id="DrugDDI.d540.s84.e0" origId="s84.p460" charOffset="18-27" type="drug" text="rifabutin"/><entity id="DrugDDI.d540.s84.e1" origId="s84.p465" charOffset="77-85" type="drug" text="CRIXIVAN"/><entity id="DrugDDI.d540.s84.e2" origId="s84.p474" charOffset="156-165" type="drug" text="rifabutin"/><entity id="DrugDDI.d540.s84.e3" origId="s84.p476" charOffset="170-178" type="drug" text="CRIXIVAN"/><pair id="DrugDDI.d540.s84.p0" e1="DrugDDI.d540.s84.e0" e2="DrugDDI.d540.s84.e1" interaction="false"/><pair id="DrugDDI.d540.s84.p1" e1="DrugDDI.d540.s84.e0" e2="DrugDDI.d540.s84.e2" interaction="false"/><pair id="DrugDDI.d540.s84.p2" e1="DrugDDI.d540.s84.e0" e2="DrugDDI.d540.s84.e3" interaction="false"/><pair id="DrugDDI.d540.s84.p3" e1="DrugDDI.d540.s84.e1" e2="DrugDDI.d540.s84.e2" interaction="false"/><pair id="DrugDDI.d540.s84.p4" e1="DrugDDI.d540.s84.e1" e2="DrugDDI.d540.s84.e3" interaction="false"/><pair id="DrugDDI.d540.s84.p5" e1="DrugDDI.d540.s84.e2" e2="DrugDDI.d540.s84.e3" interaction="true"/></sentence><sentence id="DrugDDI.d540.s85" origId="s85" text="Sildenafil"><entity id="DrugDDI.d540.s85.e0" origId="s85.p479" charOffset="0-10" type="drug" text="Sildenafil"/></sentence><sentence id="DrugDDI.d540.s86" origId="s86" text="? sildenafil concentration"><entity id="DrugDDI.d540.s86.e0" origId="s86.p481" charOffset="2-12" type="drug" text="sildenafil"/></sentence><sentence id="DrugDDI.d540.s87" origId="s87" text="Sildenafil dose should not exceed a maximum of 25 mg in a 48- hour period in patients receiving concomitant indinavir therapy."><entity id="DrugDDI.d540.s87.e0" origId="s87.p482" charOffset="0-10" type="drug" text="Sildenafil"/><entity id="DrugDDI.d540.s87.e1" origId="s87.p491" charOffset="108-117" type="drug" text="indinavir"/><pair id="DrugDDI.d540.s87.p0" e1="DrugDDI.d540.s87.e0" e2="DrugDDI.d540.s87.e1" interaction="true"/></sentence><sentence id="DrugDDI.d540.s88" origId="s88" text="Tadalafil"><entity id="DrugDDI.d540.s88.e0" origId="s88.p492" charOffset="0-9" type="drug" text="Tadalafil"/></sentence><sentence id="DrugDDI.d540.s89" origId="s89" text="? tadalafil concentration"><entity id="DrugDDI.d540.s89.e0" origId="s89.p494" charOffset="2-11" type="drug" text="tadalafil"/></sentence><sentence id="DrugDDI.d540.s90" origId="s90" text="Tadalafil dose should not exceed a maximum of 10 mg in a 72- hour period in patients receiving concomitant indinavir therapy."><entity id="DrugDDI.d540.s90.e0" origId="s90.p495" charOffset="0-9" type="drug" text="Tadalafil"/><entity id="DrugDDI.d540.s90.e1" origId="s90.p504" charOffset="107-116" type="drug" text="indinavir"/><pair id="DrugDDI.d540.s90.p0" e1="DrugDDI.d540.s90.e0" e2="DrugDDI.d540.s90.e1" interaction="true"/></sentence><sentence id="DrugDDI.d540.s91" origId="s91" text="Vardenafil"><entity id="DrugDDI.d540.s91.e0" origId="s91.p505" charOffset="0-10" type="drug" text="Vardenafil"/></sentence><sentence id="DrugDDI.d540.s92" origId="s92" text="? vardenafil concentration"><entity id="DrugDDI.d540.s92.e0" origId="s92.p507" charOffset="2-12" type="drug" text="vardenafil"/></sentence><sentence id="DrugDDI.d540.s93" origId="s93" text="Vardenafil dose should not exceed a maximum of 2.5 mg in a 24-hour period in patients receiving concomitant indinavir therapy."><entity id="DrugDDI.d540.s93.e0" origId="s93.p508" charOffset="0-10" type="drug" text="Vardenafil"/><entity id="DrugDDI.d540.s93.e1" origId="s93.p517" charOffset="108-117" type="drug" text="indinavir"/><pair id="DrugDDI.d540.s93.p0" e1="DrugDDI.d540.s93.e0" e2="DrugDDI.d540.s93.e1" interaction="false"/></sentence><sentence id="DrugDDI.d540.s94" origId="s94" text="Note: ?"/><sentence id="DrugDDI.d540.s95" origId="s95" text="= increase;"/><sentence id="DrugDDI.d540.s96" origId="s96" text="? = decrease"/><sentence id="DrugDDI.d540.s97" origId="s97" text="? ?"/></document>